首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Note: Resistance to Multiple Fluoroquinolones in a Clinical Isolate of Streptococcus pyogenes: Identification of gyrA and parC and Specification of Point Mutations Associated with Resistance
【2h】

Note: Resistance to Multiple Fluoroquinolones in a Clinical Isolate of Streptococcus pyogenes: Identification of gyrA and parC and Specification of Point Mutations Associated with Resistance

机译:注意:化脓性链球菌临床分离株中对多种氟喹诺酮类药物具有耐药性:gyrA和parC的鉴定以及与耐药性相关的点突变的规范

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

A strain of Streptococcus pyogenes resistant to multiple fluoroquinolones was isolated from the blood of an immunocompromised patient. Resistance to fluoroquinolones in S. pyogenes has not been previously studied. Compared to 10 sensitive strains of S. pyogenes, the fluoroquinolone-resistant clinical isolate of S. pyogenes presented point mutations in gyrA, predicting that serine-81 was changed to phenylalanine and that methionine-99 was changed to leucine, and in parC, predicting that serine-79 was changed to tyrosine. The mechanism of fluoroquinolone resistance in this isolate of S. pyogenes appears to be analogous to previously reported mechanisms for Streptococcus pneumoniae.
机译:从免疫受损患者的血液中分离出对多种氟喹诺酮类耐药的化脓性链球菌菌株。化脓性链球菌对氟喹诺酮类药物的耐药性先前尚未研究。与10个敏感的化脓性链球菌菌株相比,耐化脓性链球菌的临床分离株在gyrA中出现点突变,预测丝氨酸81变为苯丙氨酸,蛋氨酸99变为亮氨酸,在parC中预测丝氨酸79被改为酪氨酸。化脓性链球菌分离物中氟喹诺酮耐药的机制似乎与先前报道的肺炎链球菌的机制相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号